Access
To read this story in full you will need to login or make a payment (see right).
Review
Nature Medicine 12, 1016 - 1022 (2006)
Published online: 7 September 2006 | doi:10.1038/nm1478
Pathophysiologically based treatment interventions in schizophrenia
David A Lewis1,2 & Guillermo Gonzalez-Burgos1
Abstract
Identifying the molecular alterations that underlie the pathophysiology of critical clinical features of schizophrenia is an essential step in the rational development of new therapeutic interventions for this devastating illness. Cognitive deficits, such as the impairments in working memory that arise from dysfunction of the dorsolateral prefrontal cortex, are a major determinant of functional outcome in schizophrenia. Here we consider the contributions of disturbances in glutamate, dopamine and GABA neurotransmission to the pathophysiology of working memory impairments in schizophrenia, suggest a cascade of molecular events that might link these disturbances, and argue that the molecular alterations most proximal to the pathophysiology of prefrontal dysfunction offer the most promise as targets for new drug development.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Losing inhibition with ketamineNature Chemical Biology News and Views (01 Feb 2008)
Schizophrenia: signals from the other sideNature Medicine News and Views (01 Jul 2006)
RESEARCH
D2-40 antibody immunoreactivity in developing human brain, brain tumors and cultured neural cellsModern Pathology Original Article
See all 65 matches for Research